Elisa Bartolini
YOU?
Author Swipe
View article: Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real‐Word, Multicenter Study
Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real‐Word, Multicenter Study Open
Background & Aims Glecaprevir/Pibrentasvir (GLE/PIB) has been approved by the European Medicine Agency (EMA) and by the US Food and Drug Administration (US‐FDA) for the treatment of children and adolescents from 3 years of age with chronic…
View article: Paediatric-onset autoimmune liver disease: Insights from a monocentric experience
Paediatric-onset autoimmune liver disease: Insights from a monocentric experience Open
View article: Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child
Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child Open
View article: Growing Strong and Healthy with Mister Bone: An Educational Program to Have Strong Bones Later in Life
Growing Strong and Healthy with Mister Bone: An Educational Program to Have Strong Bones Later in Life Open
Optimal peak bone mass and bone health later in life are favored by a sufficient calcium intake in infancy, childhood and adolescence. The purpose of this study was to test a new educational program created to monitor and to improve calciu…
View article: Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission
Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission Open
Summary Background Natural killer (NK) cells number, phenotypes and function have been evaluated in many studies in adults with hepatitis C as compared with healthy controls or dynamically during interferon‐based and interferon‐free treatm…